John Augelli 

Associate – New York
T.+1 212 504 6136
200 Liberty Street
New York, NY 10281 V-CARD

John Augelli focuses his practice on intellectual property matters in a variety of technology areas. He represents clients in patent infringement lawsuits filed in U.S. District Courts, including the Eastern District of Texas, Western District of Texas, Central District of California, and Southern District of New York. John also has experience before the International Trade Commission and the Patent Trial and Appeal Board. John has experience in all phases of litigation, including fact and expert discovery, motion practice, trial, and appellate proceedings.

John also counsels clients with respect to intellectual property licensing agreements and transactions. He is admitted to practice before the U.S. Court of Appeals for the Federal Circuit, the U.S. District Court for the Southern District of New York, and the State of New York. John was named by Super Lawyers as a New York Rising Star for Intellectual Property in 2023.   

John received his J.D. from Brooklyn Law School, where he was a member of the Brooklyn Law Review and Moot Court Honor Society. John earned his B.S. in Electrical and Computer Engineering from Lafayette College. Prior to law school, he worked as a product development engineer for Amphenol Corporation.

  • Open Text Corp. v. Hyland UK Operations Limited (W.D. Tex. 2020); Open Text Corp. v. Hyland Software, Inc. (C.D. Cal. 2020): Defending Hyland UK (f/k/a Alfresco Software, Ltd.) and Hyland in patent infringement case about enterprise content management software. Successfully transferred the three Hyland UK cases from the Western District of Texas to the Central District of California and consolidated them with the cases against Hyland Software. Transfer was granted while our petition at the Federal Circuit for mandamus relief was pending when the Western District of Texas (Albright, J.) sua sponte reversed its denial of our motion to transfer. On our Rule 12 motion, the Special Master has recommended that two of the asserted patents are ineligible for patenting under Section 101.
  • C.R. Bard, Inc. v. AngioDynamics, Inc., (D. Del.): Defended AngioDynamics through trial against allegations of patent infringement relating to implantable vascular access medical devices. At trial, Plaintiff Bard (a subsidiary of Becton Dickinson) sought over $100 million in damages. Following a successful Rule 50(a) motion, the Court issued a complete judgment in favor of AngioDynamics finding no infringement (including no willful infringement), invalidity (including under Sections 102 and 112), and ineligibility under Section 101.
  • TriOptima Ltd.  v. Quantile Technologies, Ltd. (E.D. Tex., P.T.A.B.): Represented Quantile in the Eastern District of Texas (Gilstrap, J.) against allegations of patent infringement and trade secret misappropriation. The case was dismissed on Quantile’s motion to dismiss for lack of personal jurisdiction. Alongside the litigation in the Eastern District of Texas, Cadwalader also represented Quantile in a covered business method review at the PTAB. All claims were found ineligible for patenting under Section 101 at the PTAB during those proceedings.
  • Certain Beverage Dispensing Systems and Components Thereof (U.S.I.T.C. 2018): Defended Anheuser-Busch InBev in the International Trade Commission against allegations of patent infringement related to beer dispensing devices.
  • NewMarket Pharmaceuticals, LLC v. VetPharm, Inc. (American Arbitration Association 2019): Obtained a complete victory for NewMarket in a five day arbitration.
John Augelli 


  • U.S. Court of Appeals for the Federal Circuit
  • U.S. District Court, Southern District of New York
  • New York


  • Brooklyn Law School
    J.D., cum laude
  • Lafayette College